YSPR – European Stroke Organisation https://eso-stroke.org the voice of stroke in Europe Tue, 24 Feb 2026 10:37:26 +0000 en-GB hourly 1 https://wordpress.org/?v=6.8.3 Back To Bedside: First, do no harm? https://eso-stroke.org/back-to-bedside-first-do-no-harm/ Fri, 27 Feb 2026 04:36:07 +0000 https://eso-stroke.org/?p=41437 <p>The post Back To Bedside: First, do no harm? first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

Back to Bedside Graphic VisualAuthor: Iain McGurgan

Lausanne University Hospital, Switzerland

Iain McGurgan presents the fourth episode of the Back to Bedside programme.

In acute stroke care, decisions that shape long-term outcomes must be made within minutes. This case examines the complexity of acute treatment when risk factors and potential contraindications lie within the gray areas of existing guidelines, underscoring the challenges of translating evidence-based recommendations into individualised decision-making at the patient’s bedside.

Learn more and listen to the presentation

_

ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2026 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.

<p>The post Back To Bedside: First, do no harm? first appeared on European Stroke Organisation.</p>

]]>
Back To Bedside: Fading Memory https://eso-stroke.org/back-to-bedside-fading-memory/ Fri, 23 Jan 2026 04:36:36 +0000 https://eso-stroke.org/?p=41059 <p>The post Back To Bedside: Fading Memory first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

Back to Bedside Graphic VisualAuthor: Ellis van Etten

Leiden University Medical Center, the Netherlands

In the third episode of the Back to Bedside programme, Ellis van Etten presents a case of a basilar artery occlusion presenting with amnesia, highlighting the diagnostic challenges of strokes in the posterior circulation. The presentation walks participants through key clinical clues.

Learn more and listen to the presentation

In an era overflowing with neuroimaging, vascular studies, lab tests, and AI-powered diagnostics, it’s easy to forget the value of simply looking at the patient. But when it comes to clinical reasoning, no algorithm can replace a skilled clinician.

This monthly case series is here to sharpen your bedside techniques, challenge your diagnostic thinking, and help you stay grounded in what matters most: the patient.

Back to Bedside reminds us why bedside neurology still matters greatly. From asking the right questions to interpreting subtle signs and deciding what really needs to be tested, clinical skills remain at the heart of good stroke care.

_

ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2026 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.

<p>The post Back To Bedside: Fading Memory first appeared on European Stroke Organisation.</p>

]]>
The ESO YSPR Committee: Looking back on 2025, looking ahead to 2026 https://eso-stroke.org/the-eso-yspr-committee-looking-back-on-2025-looking-ahead-to-2026/ Thu, 01 Jan 2026 14:33:12 +0000 https://eso-stroke.org/?p=40526 <p>The post The ESO YSPR Committee: Looking back on 2025, looking ahead to 2026 first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

visual from ESOC 2025, hallway with people moving and large screen displaying #VoiceOfStrokeAuthor: Märit Jensen & Ellis van Etten

As 2025 has drawn to a close, the ESO YSPR committee reflects on a productive and inspiring year and looks forward to launching exciting initiatives throughout 2026.

A major highlight of 2025 was ESOC in Helsinki, Finland. Once again, the conference provided an excellent platform for scientific exchange and networking among stroke professionals from across Europe and beyond. The YSPR Research Design Workshop was well received, giving young researchers the opportunity to present their study ideas and receive structured, constructive feedback from experienced mentors.

Together with the European Stroke Journal (ESJ), the YSPR Young Reviewer Programme continued successfully in 2025. The participants for the current round have been selected, and this cycle will conclude in April 2026. Building on the strong interest and engagement seen so far, the call for new candidates for the ESJ Young Reviewer Programme will open after ESOC 2026.

The Department to Department Programme continued to offer valuable opportunities for young stroke physicians to experience different clinical and research environments across Europe. Those interested in applying are encouraged to read the previous participant reports published on the ESO blog, which provide insightful first-hand perspectives on the programme.

The ESO blog continues to be an important platform for presenting current topics and sharing perspectives. Working on the blog remains a great part of our committee work. We would like to thank everyone who contributed over the past year, and we are always happy to welcome new guest bloggers with fresh views on timely and relevant stroke-related topics.

Looking ahead to 2026

The coming year will mark the start of a new YSPR initiative: Back to Bedside. This programme aims to present short, focused clinical vignettes with clear take-home messages, highlighting the importance of clinical reasoning and bedside neurology in everyday stroke care. In case you have missed the first episodes, you can listen here to Episode 1 and Episode 2

Finally, we would like to thank all ESO members, collaborators, mentors, and participants for their continued support and engagement.

We wish everyone a successful 2026 and look forward to seeing you in person in Maastricht at the 12th ESOC!

_

ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2026 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.

<p>The post The ESO YSPR Committee: Looking back on 2025, looking ahead to 2026 first appeared on European Stroke Organisation.</p>

]]>
Back To Bedside: The Stroke Impostor https://eso-stroke.org/back-to-bedside-the-stroke-impostor-2/ Thu, 11 Dec 2025 18:34:22 +0000 https://eso-stroke.org/?p=40231 <p>The post Back To Bedside: The Stroke Impostor first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

Back to Bedside Graphic VisualAuthor: Bogdan Ciopleias

Faculty of Medicine, Transilvania University Brasov, Romania

X: @bciopleias

In the second episode of the Back to Bedside programme, Bogdan Ciopleias presents a compelling case of a stroke mimic, highlighting the diagnostic challenges encountered in acute neurovascular care. The presentation walks participants through key clinical clues.

Learn more and listen to the presentation

In an era overflowing with neuroimaging, vascular studies, lab tests, and AI-powered diagnostics, it’s easy to forget the value of simply looking at the patient. But when it comes to clinical reasoning, no algorithm can replace a skilled clinician.

This monthly case series is here to sharpen your bedside techniques, challenge your diagnostic thinking, and help you stay grounded in what matters most: the patient.

Back to Bedside reminds us why bedside neurology still matters greatly. From asking the right questions to interpreting subtle signs and deciding what really needs to be tested, clinical skills remain at the heart of good stroke care.

_

ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2026 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.

<p>The post Back To Bedside: The Stroke Impostor first appeared on European Stroke Organisation.</p>

]]>
Back To Bedside: Introducing the first Case with João Pedro Marto https://eso-stroke.org/back-to-bedside-introducing-the-first-case-with-joao-pedro-marto/ Wed, 26 Nov 2025 08:44:06 +0000 https://eso-stroke.org/?p=39990 <p>The post Back To Bedside: Introducing the first Case with João Pedro Marto first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

Back to Bedside Graphic VisualAuthor: João Pedro Marto

Introducing the First ESO Back2Bedside Case.

In an era overflowing with neuroimaging, vascular studies, lab tests, and AI-powered diagnostics, it’s easy to forget the value of simply looking at the patient. But when it comes to clinical reasoning, no algorithm can replace a skilled clinician (for now).

In this first ESO Back2Bedside video, João Pedro Marto reminds us why bedside neurology still matters greatly. From asking the right questions to interpreting subtle signs and deciding what really needs to be tested, clinical skills remain at the heart of good stroke care.

This monthly case series is here to sharpen your bedside techniques, challenge your diagnostic thinking, and help you stay grounded in what matters most: the patient.

Watch the first episode and start your journey back to the bedside.

This theme is echoed by Professor Patrik Michel, who reminds us what truly defines expert clinical care:

“With plenty of neuroimaging, vascular exams, labs, and other ancillary tests, does anyone still need to look at the patient? Especially if my chat program listens on my behalf, and proposes a stroke territory, etiology, and detects all the stroke mimics?
Well, focusing our questioning on particular parts of the history, listening between the lines, picking up subtle signs on bedside exams, and letting yourself be driven by hypothesis generation is not a GPT business. Only clinicians can reliably collect meaningful data, value and dismiss clinical information as it comes in, decide on significant and useless additional exams, and communicate all the findings effectively with colleagues and patients.
The monthly ESO Back2Bedside case will help you to be a master of clinical skills rather than the slave of ancillary exams, by refreshing your neurological bedside skills and your clinical reasoning.”

_

ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2026 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.

<p>The post Back To Bedside: Introducing the first Case with João Pedro Marto first appeared on European Stroke Organisation.</p>

]]>
ESO TF4UKR D2D Visiting Programme – Inna Savchyna https://eso-stroke.org/eso-tf4ukr-department-to-department-inna-savchyna/ Fri, 24 Oct 2025 03:00:33 +0000 https://eso-stroke.org/?p=39316 <p>The post ESO TF4UKR D2D Visiting Programme – Inna Savchyna first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

Author: Inna Savchyna

Host Institution: Stroke Unit, Hospital de Santa Maria, Lisbon, Portugal

As part of the ESO TF4UKR Department-to-Department Visiting Programme, I had the privilege of completing a ten-day internship at the Stroke Unit of the University Hospital de Santa Maria under the supervision of Professor Ana Catarina Gaspar Fonseca, a highly qualified neurologist with extensive expertise in cerebrovascular medicine. Hospital de Santa Maria is the largest university hospital in Portugal and the country’s leading medical center, closely affiliated with the University of Lisbon. The Department of Neurology and Stroke Unit plays a central role in providing specialised care while integrating clinical practice, scientific research, and teaching.

During the internship, I followed the full pathway of patients with acute stroke – from admission at the emergency department to clinical evaluation, neuroimaging, and decision-making regarding treatment (thrombolysis or mechanical thrombectomy). Particular attention was given to ensuring alignment between presenting symptoms and diagnostic findings, which enabled a highly personalised approach to each patient. The Stroke Unit can be highly estimated by its high level of organisation: efficient triage, standardised imaging protocols, and well-coordinated teamwork of a multidisciplinary staff (neurologists, interventional neuroradiologists, anesthesiologists, and nurses). A key feature was that physicians strictly adhered to acute ischemic stroke treatment protocols, and patients are sure to receive timely and effective care. The level of interventional stroke therapy meets the highest international standards.

The atmosphere at the Stroke Unit was exceptionally welcoming and hospitable. Doctors were eager to share their expertise, explain the organisational structure of stroke care in Portugal, and engage me in clinical discussions. I also had the opportunity to observe other departments of the hospital, which provided a broader perspective on how practical stroke care is integrated within a large university medical center.

I am deeply grateful to Professor Ana Catarina Gaspar Fonseca as well as the entire team of the Stroke Unit at Hospital de Santa Maria, and the ESO TF4UKR programme for this invaluable professional experience.

Learn more about the TF4UKR Programme: https://eso-stroke.org/resources/tf4ukr/


ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2026 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.

<p>The post ESO TF4UKR D2D Visiting Programme – Inna Savchyna first appeared on European Stroke Organisation.</p>

]]>
ESO TF4UKR Department-to-Department Visiting Programme https://eso-stroke.org/eso-tf4ukr-department-to-department-visiting-program-8-2/ Tue, 07 Oct 2025 03:00:11 +0000 https://eso-stroke.org/?p=38176 <p>The post ESO TF4UKR Department-to-Department Visiting Programme first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

Author: Yuliia Zashchypas

 

Host Institution: Karolinska University Hospital & Danderyd Hospital, Stockholm, Sweden

An incredible learning experience at Karolinska University Hospital through the D2D programme by the European Stroke Organisation (ESO)!

Together with a physician in physical and rehabilitation medicine (Dr. Guliaieva) we observed the highly skilled work of a multidisciplinary team: doctors, nurses, speech &language therapists, and other specialists.

During my clinical training at Karolinska University Hospital in Stockholm, I had the opportunity to observe and participate in the work of speech and language therapists (SLTs) in both acute and post-acute care settings. This was an extremely valuable and enriching experience that allowed me to broaden my professional knowledge and gain insight into interdisciplinary collaboration in a world-renowned medical facility.

Part of the SLT team works with patients in the acute phase of their condition, particularly those in intensive care units (ICUs). I had the opportunity to accompany the SLTs during the clinical assessment of such patients. Additionally, I was involved in two gold-standard instrumental swallowing assessments: Fiberoptic Endoscopic Evaluation of Swallowing (FEES) and Videofluoroscopic Swallow Study (VFSS). These procedures were followed by team discussions to determine appropriate therapeutic strategies and treatment plans based on the results.

I also participated in the diagnostic process for patients with head and neck cancer. These patients were evaluated both before and after tumor resection. It was insightful to observe how assessments and therapy planning are tailored to each patient’s condition and surgical outcomes.

Furthermore, I visited a rehabilitation center where patients stay after the acute phase of their illness. There, I observed the evaluation and treatment of patients with aphasia. I attended outpatient rehabilitation sessions and became familiar with the tools and scales used for aphasia diagnostics. Among these were standardised assessments such as:

  • Western Aphasia Battery (WAB)
  • Boston Diagnostic Aphasia Examination (BDAE)
  • Aachen Aphasia Test (AAT)

This clinical experience deeply inspired me. I was particularly impressed by the professionalism, empathy, and scientific approach demonstrated by every member of the speech and language therapy team. The high level of interdisciplinary cooperation and the attention given to each individual patient were exemplary and serve as a model for clinical work.

I am sincerely grateful to the entire SLT team at Karolinska University Hospital for their openness, support, and willingness to share their experience and knowledge. Their mentorship made my stay not only educational but also personally meaningful. This training has strengthened my motivation to continue developing in the field of speech-language pathology and to implement the best international practices in my own work.


ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2026 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.

<p>The post ESO TF4UKR Department-to-Department Visiting Programme first appeared on European Stroke Organisation.</p>

]]>
ESO TF4UKR D2D Visit Programme — Mariia Mykhailova https://eso-stroke.org/eso-tf4ukr-blog-department-to-department-visiting-program-mariia-mykhailova/ Fri, 03 Oct 2025 03:00:55 +0000 https://eso-stroke.org/?p=38940 <p>The post ESO TF4UKR D2D Visit Programme — Mariia Mykhailova first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

Author: Mariia Mykhailova

 

Host Institution: Stroke Unit, Mater Misericordiae University Hospital, Dublin

My name is Mariia Mykhailova, and I am a neurology resident at the Stroke Centre of Oberig Universal Clinic in Kyiv, Ukraine. With the support of the ESO TF4UKR Department to Department Visit Programme, I had the opportunity to complete a two-week clinical observership at the Stroke Unit of Mater Misericordiae University Hospital in Dublin. I was warmly welcomed by the team and had the opportunity to closely observe clinical practice under the supervision of consultant neurologists Professor Peter Kelly and Dr. Michael Marnane, who generously shared their expertise. Their guidance and openness were incredibly valuable, and I am excited to bring many of the insights I gained back to my work in Ukraine.

Throughout the observership, I was able to observe the full continuum of stroke care, including emergency assessments, inpatient rounds, and outpatient follow-ups. I was particularly impressed by how well-coordinated and fast the stroke team operated upon patient arrival. It was also remarkable to see how openly doctors consulted with one another – less experienced clinicians receiving real-time support and guidance from senior colleagues, including remotely when needed. This collaborative approach stood out to me as a strength and gave me ideas for enhancing shared decision-making in our own practice.

It was also valuable to observe the structure and operations of the Hyper Acute Stroke Unit (HASU), as such units are not yet common in Ukraine. The clearly defined workflows and systematic documentation offered a clear and efficient model that could be beneficial in our context.

I attended multidisciplinary meetings and joined one of the radiology case discussions, where consultants and radiologists reviewed selected imaging cases together. This kind of collaborative review was a helpful addition to clinical decision-making and could be a useful format to implement in our own practice.

At the outpatient clinic, I observed structured follow-up visits 3–6 months after discharge. I found the discharge booklet given to each patient particularly impressive – it includes a summary of their condition, relevant contacts, lifestyle recommendations, and diaries for tracking blood pressure and lab results. This kind of patient-centred resource could be very helpful if adapted for use in Ukrainian stroke services.

In addition, I learned several therapeutic approaches that were new to me, including aspects of blood pressure management in acute stroke. I was also inspired by how well the system supports rehabilitation after discharge – from social worker involvement to options for continued care at home or in rehabilitation centres. These practices could significantly improve stroke recovery outcomes if integrated into our own system.

This observership gave me the chance to compare stroke care in two different healthcare systems and reflect on what could be adapted locally. I also had the opportunity to build professional connections that I hope will lead to future collaboration and knowledge exchange.

Overall, this was a highly enriching and motivating experience. I am sincerely grateful to the European Stroke Organisation for supporting this opportunity, and I look forward to applying what I’ve learned to strengthen stroke care in Ukraine.


ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2026 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.

<p>The post ESO TF4UKR D2D Visit Programme — Mariia Mykhailova first appeared on European Stroke Organisation.</p>

]]>
ESJ Featured Article of the Month – September 2025: Results of the PRACTISE Trial https://eso-stroke.org/esj-featured-article-of-the-month-september-2025/ Fri, 26 Sep 2025 03:56:45 +0000 https://eso-stroke.org/?p=38926 <p>The post ESJ Featured Article of the Month – September 2025: Results of the PRACTISE Trial first appeared on European Stroke Organisation.</p>

]]>
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; }

Author: Dr. Sarah Gorey

X: @sarah_gorey

This month in the European Stroke Journal, Keith Muir and colleagues present the results of the PRACTISE trial.

This randomised controlled trial sought to compare two different acute stroke imaging approaches (non-contrast CT compared to multimodal CT which included CT angiogram and CT perfusion ) and to assess the influence of initial imaging on thrombolysis rates.

When this trial was conceived, the hypothesis was that the addition of CTA and CTP would increase the likelihood of receiving thrombolytic treatment within 4.5 hours, by identifying more patients with vessel occlusion or perfusion mismatch who would not otherwise have been identified by NCCT. This trial would also be able to tackle the question of whether performing advanced imaging in addition to NCCT delays the time to decision and the door to needle time.

The PRACTISE trial was conducted from March 2015 to May 2018 at 11 UK sites, all of which were established thrombolysis centres participating in the national UK stroke audit and with prior experience of multimodal imaging. The study recruited adult patients presenting with signs and symptoms consistent with acute ischaemic stroke within 4.5 hours of symptom onset, who were potentially eligible for thrombolysis. All patients provided informed consent. Included patients were randomised in a 1:1 ratio to either non-contrast CT (NCCT) or multimodal CT (NCCT+CTA +CTP). If the initial NCCT identified a contraindication to thrombolysis such as intracranial haemorrhage, the patient was regarded as a screen failure and was excluded from the study. All scans were analysed locally at the participating hospital site and treatment decisions made by the local treating physician according to current UK guidelines. The trial also collected the imaging data and centrally analysed the results to assess agreement with the treating sites.

In total, 271 patients were randomised, 134 to multimodal CT and 137 to NCCT. Recruitment was ceased after funding became unavailable. The original sample size calculation estimated that 200 subjects per group was required to detect an increase in the proportion treated with thrombolysis from 25% to 40% (an absolute change of 15%), with a power of 80%, allowing for post randomisation exclusions for non-stroke pathology. This means that the trial is underpowered to definitively answer its primary aim.

After initial imaging was performed, 49 of the 271 patients were excluded due to contraindications for thrombolysis- the most common reasons were intracerebral haemorrhage (in 24) and non-stroke pathology (in 10). There were 114 remaining thrombolysis eligible patients in the multimodal CT arm and 108 in the NCCT arm. The average age of participants was 67.5 years, and 45.6% were women. The median NIHSS score was 6 (IQR 3-12). The median time to randomisation was 122 minutes (IWR 90-165). Of those randomised to receive multimodal CT, 94% had CTA performed and 91% had CTP. Of those randomised to receive NCCT alone, 17% also received CTA, but none received CTP.

The primary outcome of this trial was the proportion receiving thrombolysis. Overall 57.7% of patients included in this trial received thrombolysis. Less patients receiving multimodal CT (56/114, 49.1%) received IV thrombolysis compared to those receiving NCCT (73/108, 67.6%); adjusted odds ratio 0.46 (95% CI 0.25-0.83, p=0.01). This was the opposite direction of effect to what the investigators originally hypothesised.

Importantly, the time from symptom-onset to treatment decision did not differ between the two imaging strategies: in the multimodal group the median was 131minutes (IQR 116-180) and 135 minutes (IQR 108-170) for the NCCT group (p=0.64). Neither was there a difference in onset to needle time: 144 minutes (IQR120-184) for the multimodal CT arm compared with 145 minutes (IQR 118-174) for the NCCT arm. Additionally, there was no difference in functional outcome (measured by modified Rankin scale) between imaging strategies. There were numerically less deaths in those receiving multimodal CT (6/114 [5.3%]) compared to those receiving NCCT (11/108, [10.2%], p=0.2).

Some imaging findings were strongly associated with an increased likelihood of receiving thrombolysis including ASPECTS score <10, presence of intracranial occlusion identified on CTA or the presence of a perfusion mismatch on CTP. Every patient with CTP mismatch identified in this trial received thrombolysis. Conversely, 51 patients were not treated based on the results of advanced imaging as there was no evidence of vessel occlusion, of acute ischaemic change or of perfusion mismatch. Patients who did not receive thrombolysis in this trial had a lower median NIHSS score of 4, and were more likely to have isolated or mild symptoms.

This is the first trial to randomise patients to NCCT or multimodal CT imaging in the acute phase of stroke within the 4.5 hour window for thrombolysis. Multimodal CT was associated with reduced thrombolysis treatment rates, but without evidence of a time delay in treatment or differences in functional outcomes. Additionally, there were numerically fewer intracerebral haemorrhages and deaths in those receiving multimodal CT.

It is likely that appropriate exclusion of stroke mimics was one factor in the results of this trial. In the UK stroke audit, stroke mimics were estimated to account for 31% of all acute presentations to hospital services and up to half of all stroke assessments performed. While the risk of intracerebral haemorrhage occurring when thrombolysis is given to a patient with a stroke mimic is lower than for acute ischaemic stroke, it still occurs in about 1% of cases, with potentially serious or fatal consequences. Furthermore, the authors observe that the additional time taken to perform multimodal imaging was offset by a slightly shorter treatment decision time as the decision making was often less complex after incorporating additional information based on the results of  CTA and CTP.

This trial suggests that widespread use of multimodal CT to assess patients with suspected acute ischaemic stroke within 4.5 hours of onset, who are eligible for thrombolysis would reduce thrombolysis treatment rates, but may increase the accuracy of treatment decisions – meaning thrombolysis treatment is better targeted at patients most likely to benefit. Further analysis is needed to calculate potential cost savings due to reduced thrombolysis use and lower number of complications balanced against the increased cost and resource implications of more widespread scanning. It is worth remembering that this study did not recruit to full sample size planned by the power calculation due to lack of funding. Additionally, functional outcomes were not the primary outcome of this trial, and a further trial would be required to confirm that there is truly no difference in functional outcome associated with different imaging modalities. Nevertheless it is interesting to observe that the direction of effect is opposite to what the investigators had hypothesised, but more data is needed to confirm this finding.

_

ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2025 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.

<p>The post ESJ Featured Article of the Month – September 2025: Results of the PRACTISE Trial first appeared on European Stroke Organisation.</p>

]]>